Minerva Neurosciences (NERV) Misses Q4 EPS by 25c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($1.26), $0.25 worse than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Rubico to shift from semi-annual to quarterly financial reporting
• Raymond James Reiterates Underperform Rating on Lennar (LEN)